Lilly Confirms Date and Conference Call for 2023 Financial Guidance Announcement
Eli Lilly and Company (NYSE: LLY) will announce its 2023 financial guidance on Dec. 13, 2022. A conference call with the investment community and media will take place at 9 a.m. Eastern time on the same day to detail the guidance. Investors and the public can access a live webcast through Lilly's website, with a replay available afterward. Lilly has a long history of creating innovative medicines that enhance lives globally, addressing critical health challenges like diabetes, obesity, and cancer.
- Scheduled announcement of 2023 financial guidance may provide clarity and direction for investors.
- The conference call offers an opportunity for direct communication between the company and its stakeholders.
- None.
INDIANAPOLIS, Nov. 29, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial guidance for 2023 on Tuesday, Dec. 13, 2022. Lilly will also conduct a conference call on that day with the investment community and media to further detail the company's financial guidance.
The conference call will begin at 9 a.m. Eastern time. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at https://investor.lilly.com/webcasts-and-presentations. A replay will also be available on the website following the conference call.
About Lilly
Lilly unites caring with discovery to create medicines that make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 47 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer's disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom or follow us on Facebook, Instagram and LinkedIn. F-LLY
Refer to: | Jordan Bishop; jordan.bishop@lilly.com; 317-473-5712 (Media) |
Joe Fletcher; jfletcher@lilly.com; 317-296-2884 (Investors) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-confirms-date-and-conference-call-for-2023-financial-guidance-announcement-301688165.html
SOURCE Eli Lilly and Company
FAQ
When will Eli Lilly announce its 2023 financial guidance?
What time is Eli Lilly's conference call for financial guidance?
How can I access the conference call by Eli Lilly?
What is the purpose of Eli Lilly's conference call on December 13, 2022?
